🇺🇸 FDA

Company profile · Sponsor

A.C.O.M.

A.C.O.M. - Advanced Center Oncology

E3A5F8E · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

A.C.O.M. (E3A5F8E) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E3A5F8E
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. 64Cu(II)Cl2 solution for injection

    A.C.O.M.

    Cancer on the prostatic bed

    phase 3 small molecule active

    1 trial

  2. 64Cu(II)Cl2 solution for injection, Fluorocolina (18F) Curium Italy 225 MBq/mL soluzione iniettabile

    A.C.O.M.

    Prostate cancer at risk of developing metastatic lesions

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is A.C.O.M.?

A.C.O.M. (E3A5F8E) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does A.C.O.M. sponsor?

We track 2 ClinicalTrials.gov-linked programs for A.C.O.M., including 64Cu(II)Cl2 solution for injection and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does A.C.O.M. company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.